(19)
(11) EP 4 739 705 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24840338.8

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61P 25/28(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/18; A61P 25/28; A61K 2039/505; C07K 2317/77
(86) International application number:
PCT/US2024/036930
(87) International publication number:
WO 2025/014821 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 07.07.2023 US 202363512412 P

(71) Applicant: The Board of Regents of the University of Texas System
Austin, Texas 78701 (US)

(72) Inventor:
  • MONSON, Nancy
    Dallas, Texas 75390 (US)

(74) Representative: Rückerl, Florian 
Dehmel & Bettenhausen Patentanwälte PartmbB Herzogspitalstraße 11
80331 München
80331 München (DE)

   


(54) TARGETING HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS FOR NEUROPROTECTION